Cardimyocyte differentiation of human induced pluripotent stem cells: Modification of signaling pathways
these pathways allows efficient production of cardiomyocytes that may provide a possible source for cell-based therapy
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
these pathways allows efficient production of cardiomyocytes that may provide a possible source for cell-based therapy
With the growth of the cell-based therapy industry, one of the key challenges in the field is the successful preservation of these therapies in order to enable centralized manufacture
Cell-based therapy represents a highly promising approach for the treatment of heart diseases but its validation requires extensive preclinical studies. Major challenges include lack of clinically relevant large animal
Herein, we overview current research findings on B cell anti-tumor functions and B cell-based approaches for cancer immunotherapy. We predict that GIFT4- augmented B cells as a potent
numerous novel isolates obtained were pharmacologically screened for activity in a variety of cell-based and pure enzyme assays designed to identify promising lead compounds for the development of drugs
simultaneously impact multiple molecular pathways and signaling within cells. We have found that cell-based therapies promote neurological recovery and promote neurovascular remodeling by transferring exosomes to…
potential to differentiate into a variety of cell types for the purpose of cell-based therapies. Isolation and banking of DPSCs has attracted a large number of researchers
Dysregulation or mutation of miRNAs has been linked to autoimmune diseases such
ability of researchers and manufacturers to successfully and cost effectively manufacture and deliver engineered cell-based therapeutic products that are safe and exhibit enhanced potency with resulting durable…
With the recent US FDA approval and commercialization of the world’s first plant cell-based recombinant pharmaceutical for human use, β-glucocerebrosidase for treatment of Gaucher’s disease
custom meganuclease editing agents with extremely high levels of specificity. Delivered through a rapid cell-based screening process, ARCUS nucleases have been proven effective across a wide range of target
custom meganuclease editing agents with extremely high levels of specificity. Delivered through a rapid cell-based screening process, ARCUS nucleases have been proven effective across a wide range of target
been recognized as a viable therapeutic approach since the regulatory approval of the autologous cell-based vaccine sipuleucel-T in 2010. Emerging preclinical evidence and early-stage clinical studies point
Stem cell-based neuronal differentiation has provided a unique opportunity for regenerative medicine, disease modeling and drug discovery. Neurospheres are commonly used neuroprogenitors for neuronal differentiation but…
mesenchymal stem cells from human bone marrow (ahMSCs) are a great promise for cell-based therapies by their ability to differentiate into osteoblast in certain microenvironments. For this purpose
effort to understand this apparent hypo-responsiveness, many laboratories have utilized in vitro cell-based models as tools to probe the nature and consequences of host cell interactions with
Finally, the neurorepair strategy will be described with special emphasis on the role of cell-based therapies and ischaemic conditioning
Background: Stem cell-based therapies provide hope for various CNS diseases including perinatal hypoxic ischemic insults of the brain. Stem cells have the capacity to proliferate in culture, migrate
Stem cell-based tissue engineering has emerged as a promising avenue for treatment of liver diseases and as drug metabolism and toxicity models in drug discovery and development. In vitro
RNAs. Cutting edge research featuring stem cells will gear us to medical discovery of cell-based therapies of various diseases occurring in animals and human beings. Apart from applications
Recently, advances experimental evidence empowers the idea that diabetic patients may greatly benefit from cell-based therapies, which include the use of adult stem and/or progenitor cells in disease
pathway significantly contributes to cBMEC shedding during the pathogenesis of BBB/CNS disorders. The cell-based biomarkers cBMEC along with the single cell technology will overcome the limitations of molecular
application, it is mandatory to develop the other non-toxic nano-technological and/or cell-based delivery strategies to enhance the biocompatibility and accuracy of NCT for cancer treatment. Mesenchymal
cellular cardiomyoplasty improved cardiac function. Cellular cardiomyoplasty using hADMPC could be potentially effective cell-based therapy
Objective: Stem cell-based therapy seems to be a promising option to support regeneration after organ failure and tissue injury. The transplantation of MSCs requires cells with a maximum regenerative
For authors and organisers
Find the right journal for your paper and submit your manuscript.